Overview
Eku Shimosegawa practices in Suita, Japan. Shimosegawa is highly rated in 4 conditions, according to our data. Their top areas of expertise are Mediastinal Tumor, Glioma, Gliomatosis Cerebri, and Brain Tumor.
Their clinical research consists of co-authoring 107 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Mediastinal TumorShimosegawa isElite. Learn about Mediastinal Tumor.
- Advanced
- Brain TumorShimosegawa isAdvanced. Learn about Brain Tumor.
- GliomaShimosegawa isAdvanced. Learn about Glioma.
- Gliomatosis CerebriShimosegawa isAdvanced. Learn about Gliomatosis Cerebri.
- Experienced
- Alzheimer's DiseaseShimosegawa isExperienced. Learn about Alzheimer's Disease.
- AstrocytomaShimosegawa isExperienced. Learn about Astrocytoma.
- Cerebral HypoxiaShimosegawa isExperienced. Learn about Cerebral Hypoxia.
- DementiaShimosegawa isExperienced. Learn about Dementia.
- Esophageal CancerShimosegawa isExperienced. Learn about Esophageal Cancer.
- Follicular LymphomaShimosegawa isExperienced. Learn about Follicular Lymphoma.